Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
Benzoheterocyclic anti-bacterial agents
US9617249B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9617249-B2 |
| Application number | US-201313753356-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 29, 2013 |
| Priority date | May 30, 2008 |
| Publication date | Apr 11, 2017 |
| Grant date | Apr 11, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Embodiments herein provide compounds and methods of making and using such compounds for prevention and treatment of multidrug resistant bacteria. In particular, embodiments are directed to anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating a drug-resistant bacterial strain, comprising: administering a compound to an individual infected with or suspected of being infected with a methicillin-resistant Staphylococcus aureus strain, a vancomycin-resistant Enterococcus strain, or a linezolid-resistant Enterococcus strain, wherein the bacterial strain is killed or inhibited from growing, wherein the compound is one of the following compounds: 2. The method of claim 1 , wherein the compound is: 3. The method of claim 1 , wherein the compound is: 4. The method of claim 1 , wherein the compound is:
Assignees
Inventors
Classifications
directly linked by a ring-member-to-ring-member bond · CPC title
containing nitrogen {having a Si-N linkage} · CPC title
condensed with carbocyclic rings, e.g. benzimidazoles · CPC title
Ortho-condensed systems · CPC title
attached in position 5 · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9617249B2 cover?
- Embodiments herein provide compounds and methods of making and using such compounds for prevention and treatment of multidrug resistant bacteria. In particular, embodiments are directed to anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria.
- Who is the assignee on this patent?
- Univ Notre Dame Du Lac
- What technology area does this patent fall under?
- Primary CPC classification C07D405/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).